• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

New Medical-Grade UV Device Can Kill COVID Virus in 2 Seconds

by Fred Pennic 09/23/2020 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
New Medical-Grade UV Device Can Kill COVID Virus in 2 Seconds

What You Should Know:

– Innovators’ “NuvaWave™” launches a medical-grade, intelligent handheld UVC device that can kill the SARS-CoV-2, the virus that causes COVID-19 in two seconds.

– Initially, the founders created it for hospitals but it’s going on the market for commercial use – offices, gyms, hotels, airlines, voting booths – everywhere it’s needed so we can get back to life.


UV Innovators, an ultraviolet technology company has unveiled NuvaWave, one of the most advanced tool in the fight against deadly pathogens. NuvaWave is a UVC handheld device that is used to disinfect any high touch surface. This product release is timely as all businesses, schools, municipalities, airlines, cruise ships and other commercial ventures need to have a solution to protect their employees, students, customers, and family from COVID-19. 

NuvaWave Development

Initially, the founders created it for hospitals but it’s going on the market for commercial use – offices, gyms, hotels, airlines, voting booths – everywhere it’s needed so we can get back to life. NuvaWave was tested at Texas Biomed, an independent, nonprofit research institute whose mission is to protect our global community from the threats of infectious diseases through cutting-edge research. The results from the rigorous study completed at Texas Biomedical Research Institute demonstrated that NuvaWave killed >99.9% of the live virus in just two seconds.

For nearly three-quarters of a century, the Institute has delivered high quality and reliable scientific data, spanning basic discovery through preclinical development,” explained Dr. Cory Hallam, Professor and Vice President for Business Development at Texas Biomed. “The scientists at Texas Biomed know how to handle the live virus in their biosafety level 3 (BSL-3) lab and to use protocols to safely mimic real-world conditions that helped us document the effectiveness of NuvaWave,” added Dr. Nicholas Medendorp, CEO of UV Innovators. “NuvaWave .

New Medical-Grade UV Device Can Kill COVID Virus in 2 Seconds

NuvaWave handheld device only weighs 1.5 pounds and provides 5,000 hours of disinfection.  UV Innovators’ break-through technology changes the paradigm in making hospital-grade technology affordable. UV Innovators is announcing the NuvaWave Fleet Program starting at $199 a month that enables infection control teams a simple and affordable monthly payment.

Key Features

– Distance feedback to aid user in optimal placement

– Continuous system performance monitoring

– Embedded computer sensors for intelligent safety shut-off

– Uniform UVC light across disinfection area

– Ergonomically balanced design

– Visible light indicators of active disinfection

Why It Matters

“In order for people to feel comfortable getting back to normal, they must feel confident that the places they go are clean and free from infectious pathogens. NuvaWave is a commercial-grade solution for those who are disinfecting high-touch surfaces,” added Dr. Nicholas Medendorp, Jr., a technology leader with over two decades of LED experience and 115 patents and CEO of UV Innovators. “NuvaWave has undergone rigorous testing with accredited third-party laboratories to gauge its efficacy in killing SARS-CoV-2, the virus that causes COVID-19.,” added Dr. Medendorp.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Coronavirus (COVID-19), Patents, sensors

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

 Selecting the Right EMR: A Practical Guide to Streamlining Your Practice and Enhancing Patient Care

Selecting the Right EMR: A Practical Guide to Streamlining Your Practice and Enhancing Patient Care

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

CMS Finalizes New Interoperability and Prior Authorization Rule

CMS Proposes 2026 Physician Fee Schedule Rule: Boosting Primary Care, Cutting Waste, and Modernizing Payments

Beyond SaaS: How Agent as a Service is Transforming Healthcare Automation

Beyond SaaS: How Agent as a Service is Transforming Healthcare Automation

New Strategies Needed: No Surprises Act and the Challenges for Payors with Provider Data Inaccuracies

Samsung Acquires Xealth to Accelerate Connected Care Vision

Samsung Acquires Xealth to Accelerate Connected Care Vision

AI Dominates Digital Health Investment in First Half of 2025

Rock Health Report: AI Dominates Digital Health Investment in First Half of 2025

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |